All companies
Pfizer logo
HealthcarePFE

Pfizer (PFE) Financial Forecast Calculator

Interactive 5-year forecast and DCF for Pfizer. Adjust revenue growth, gross margin, capex intensity, WACC, and terminal growth - see revenue, free cash flow, and enterprise value update in real time. Seeded from Pfizer’s most recent SEC filings.

Revenue FY30
$95.24B
from $59.55B
FCF FY30
$34.11B
Margin 35.8%
Enterprise value
$475.81B
8.0× LTM revenue
Equity value
$412.50B
Net debt $63.31B
Revenue & free cash flow - history and 5-year forecast
Line (area)
Bars
Historicals from SEC EDGAR (grey). Forecast years (color) update live as you move the sliders.

Assumptions

Revenue growth (annual)
9.8%
-10.0%baseline 9.8%40.0%
Gross margin
68.4%
5.0%baseline 68.4%90.0%
Capex % of revenue
4.8%
0.0%baseline 4.8%30.0%
WACC (discount rate)
9.00%
4.0%baseline 9.0%18.0%
Terminal growth
2.50%
0.0%baseline 2.5%5.0%

Need this as an Excel model?

Keep iterating on the Pfizer forecast in Excel. The downloadable sample has every assumption you see here plus a fully integrated income statement, balance sheet, cash flow, and debt schedule - five years of SEC historicals and live formulas in a fully editable workbook.

income_statement.xlsx
Income statement, brown brand palette
income_statement.xlsx
Income statement, green brand palette
income_statement.xlsx
Income statement, red brand palette

Frequently asked

What does Pfizer Inc. do?+

Pfizer Inc. is a premier global biopharmaceutical company that discovers, develops, manufactures, and sells healthcare products, including innovative medicines and vaccines. The company operates a highly diversified portfolio across multiple therapeutic areas, with a current focus on oncology and internal medicine.

What are Pfizer's primary revenue drivers?+

Pfizer's revenue is largely driven by its Primary Care segment, which includes internal medicine, vaccines like the Prevnar family, and COVID-19 products such as Comirnaty and Paxlovid. Specialty Care and Oncology segments also contribute significantly, with the recent Seagen acquisition bolstering its oncology portfolio.

What is the assumed revenue growth rate for Pfizer in the financial model?+

The provided financial model assumes a revenue growth rate of approximately 9.85% for Pfizer. This growth rate is intended to capture the long-term potential from the Seagen oncology acquisition and internal pipeline, balanced against the impact of upcoming loss of exclusivity for key drugs.

How does the financial model approach Pfizer's equity valuation?+

The financial model uses a sum-of-the-parts equity valuation and pipeline scenario analysis to assess Pfizer. Its purpose is to determine if the current share price accurately reflects the long-term growth potential from the Seagen oncology acquisition and internal pipeline, considering impending patent expirations.

Can I download an Excel financial model for Pfizer?+

Yes, an Excel financial model for Pfizer is available for download. This general corporate model provides a forecast horizon from FY2026 to FY2030 and includes key assumptions for revenue growth, margins, and capital expenditures.

What is the significance of goodwill and intangible assets on Pfizer's balance sheet?+

Goodwill and identifiable intangible assets represent a very high proportion of Pfizer's total assets, approximately 45-55%. This reflects the company's strategy as a transformational acquirer, highlighted by the $43 billion Seagen acquisition and other significant deals.

Have more financial modelling questions? Contact us

Go further

Build the financial model you need with Fina

Browse templates, examples, and downloadable Excel models for the analysis you are trying to build. If you can't find your model, ask Fina to build a model for your specific needs.

Start for free
Excel financial model spreadsheet preview showing Customer Rollforward
Fina interactive chat interface preview